Total Positions
43
Quarter
2025 Q4
Top Holding
SRRK (16.9%)
Top 10 Concentration
77.8%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-25 of 43
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
SRRK
SCHOLAR ROCK HL...
|
Healthcare | 16.94% | 14.15% |
#1
Prev: #1
|
8.9 | 1,316,390 | 33.7% |
P
S
|
5,220,846 | $229,978,266 | 2018 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KRYS
KRYSTAL BIOTECH...
|
Healthcare | 12.30% | 11.36% |
#2
Prev: #2
|
6.9 | 16,317 | 2.5% |
P
S
|
677,705 | $167,081,391 | 2018 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NRIX
NURIX THERAPEUT...
|
Healthcare | 11.31% | 3.31% |
#3
7
Prev: #10
|
6.8 | 4,415,514 | 120.0% |
P
S
|
8,093,908 | $153,541,435 | 2020 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
STOK
STOKE THERAPEUT...
|
Healthcare | 9.43% | 9.55% |
#4
1
Prev: #3
|
3.8 | -141,472 | -3.4% |
P
S
|
4,034,070 | $128,041,382 | 2019 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IMNM
IMMUNOME INC
|
Healthcare | 9.05% | 5.72% |
#5
1
Prev: #6
|
5.7 | 695,000 | 13.8% |
P
S
|
5,718,385 | $122,830,910 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RGNX
REGENXBIO INC
|
Healthcare | 4.63% | 4.41% |
#6
2
Prev: #8
|
1.9 | -324,585 | -6.9% |
P
S
|
4,368,804 | $62,910,778 | 2015 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ADCT
ADC THERAPEUTIC...
|
Healthcare | 4.07% | 6.10% |
#7
2
Prev: #5
|
1.6 | no change | no change |
P
S
|
15,666,731 | $55,303,560 | 2020 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 3.76% | 3.09% |
#8
4
Prev: #12
|
1.6 | -771,200 | -34.9% |
P
S
|
1,437,918 | $51,074,847 | 2023 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ANNX
ANNEXON INC
|
Healthcare | 3.72% | 1.87% |
#9
8
Prev: #17
|
3.7 | 3,750,000 | 59.5% |
P
S
|
10,050,644 | $50,454,233 | 2020 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BEAM
BEAM THERAPEUTI...
|
Healthcare | 2.62% | 3.28% |
#10
1
Prev: #11
|
1.1 | -101,700 | -7.3% |
P
S
|
1,285,859 | $35,644,011 | 2020 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NGNE
NEUROGENE INC
|
Healthcare | 2.21% | 2.19% |
#11
3
Prev: #14
|
2.9 | 160,577 | 12.4% |
P
S
|
1,459,599 | $30,067,739 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RAPT
RAPT THERAPEUTI...
|
Healthcare | 2.21% | 1.39% |
#12
7
Prev: #19
|
3.1 | 333,333 | 60.3% |
P
S
|
885,927 | $30,006,347 | 2022 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ABSI
ABSCI CORPORATI...
|
Healthcare | 2.12% | 2.44% |
#13
Prev: #13
|
0.8 | no change | no change |
P
S
|
8,253,316 | $28,804,073 | 2021 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NUVB
NUVATION BIO IN...
|
Healthcare | 2.09% | 1.09% |
#14
9
Prev: #23
|
2.8 | 132,247 | 4.4% |
P
S
|
3,163,256 | $28,342,774 | 2021 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IDYA
IDEAYA BIOSCIEN...
|
Healthcare | 1.89% | 1.96% |
#15
1
Prev: #16
|
0.8 | no change | no change |
P
S
|
742,017 | $25,651,528 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
STTK
SHATTUCK LABS I...
|
Healthcare | 1.49% | 1.29% |
#16
4
Prev: #20
|
0.6 | no change | no change |
P
S
|
5,539,724 | $20,219,993 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SLN
SILENCE THERAPE...
|
Healthcare | 0.97% | 1.09% |
#17
5
Prev: #22
|
0.4 | no change | no change |
P
S
|
2,164,777 | $13,161,844 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ZYME
ZYMEWORKS INC
|
Healthcare | 0.95% | 6.16% |
#18
14
Prev: #4
|
0.6 | -3,214,096 | -86.7% |
P
S
|
491,654 | $12,945,250 | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
FATE
FATE THERAPEUTI...
|
Healthcare | 0.93% | 1.58% |
#19
1
Prev: #18
|
0.4 | no change | no change |
P
S
|
12,872,946 | $12,648,957 | 2015 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
REPL
REPLIMUNE GROUP...
|
Healthcare | 0.79% | 0.22% |
#20
17
Prev: #37
|
2.6 | 563,938 | 105.2% |
P
S
|
1,099,756 | $10,689,628 | 2018 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DBVT
DBV TECHNOLOGIE...
|
Healthcare | 0.78% | — |
#21
Prev: #—
|
2.3 | 549,840 | no change |
NEW
|
549,840 | $10,540,433 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SLDB
SOLID BIOSCIENC...
|
Healthcare | 0.77% | 1.14% |
#22
1
Prev: #21
|
0.3 | -38,800 | -2.0% |
P
S
|
1,860,542 | $10,493,457 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CBLL
CERIBELL INC
|
Healthcare | 0.70% | 0.49% |
#23
7
Prev: #30
|
0.3 | no change | no change |
P
S
|
435,239 | $9,544,791 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ESTA
ESTABLISHMENT L...
|
Healthcare | 0.60% | 0.52% |
#24
5
Prev: #29
|
0.3 | -16,700 | -12.9% |
P
S
|
112,664 | $8,210,952 | 2018 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ATRA
ATARA BIOTHERAP...
|
Healthcare | 0.59% | 0.62% |
#25
1
Prev: #26
|
0.2 | no change | no change |
P
S
|
441,701 | $7,990,371 | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AKRO
AKERO THERAPEUT...
|
Healthcare | 0.00% | 3.45% |
Sold All 😨
(Was: #9) |
0.3 | -747,818 | -100.0% |
CLOSED
|
— | $— | 2019 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ETNB
89BIO INC
|
Unknown | 0.00% | 2.11% |
Sold All 😨
(Was: #15) |
0.3 | -1,473,136 | -100.0% |
CLOSED
|
— | $— | 2023 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KROS
KEROS THERAPEUT...
|
Healthcare | 0.00% | 0.85% |
Sold All 😨
(Was: #24) |
0.3 | -552,506 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
FOLD
AMICUS THERAPEU...
|
Healthcare | 0.00% | 0.60% |
Sold All 😨
(Was: #27) |
0.3 | -777,178 | -100.0% |
CLOSED
|
— | $— | 2010 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
XERS
XERIS BIOPHARMA...
|
Healthcare | 0.00% | 0.36% |
Sold All 😨
(Was: #31) |
0.3 | -451,099 | -100.0% |
CLOSED
|
— | $— | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VTYX
VENTYX BIOSCIEN...
|
Healthcare | 0.00% | 0.32% |
Sold All 😨
(Was: #32) |
0.3 | -1,073,386 | -100.0% |
CLOSED
|
— | $— | 2022 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LVTX
LAVA THERAPEUTI...
|
Unknown | 0.00% | 0.31% |
Sold All 😨
(Was: #33) |
0.3 | -2,074,372 | -100.0% |
CLOSED
|
— | $— | 2021 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PRME
PRIME MEDICINE ...
|
Healthcare | 0.00% | 0.05% |
Sold All 😨
(Was: #38) |
0.3 | -87,118 | -100.0% |
CLOSED
|
— | $— | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BOLD
BOUNDLESS BIO I...
|
Healthcare | 0.00% | 0.03% |
Sold All 😨
(Was: #40) |
0.3 | -245,458 | -100.0% |
CLOSED
|
— | $— | 2016 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-25 of 43 holdings